Suprane Liquid
Product Images NDC 10019-646

6 FDA label images from Baxter Healthcare Corporation · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Suprane (NDC 10019-646). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Suprane Structural Formula (Image 01)

Suprane Structural Formula (Image 01)
Chemical structure of Desflurane, the active ingredient in SUPRANE. The diagram shows a fluorinated ether molecule with carbon, hydrogen, oxygen, and fluorine atoms arranged accordingly.*
FDA Label Image

Figure 1. Paco2 During Spontaneous Ventilation In Unstimulated Volunteers (Image 02)

Figure 1. Paco2 During Spontaneous Ventilation In Unstimulated Volunteers (Image 02)
A line graph depicting the relationship between Minimum Alveolar Concentration (MAC) on the x-axis and arterial oxygen partial pressure (PaO2) in mmHg on the y-axis. The graph compares data for Desflurane, Enflurane, Isoflurane, Desflurane with administered oxygen, and Halothane. Data points include mean values and standard errors, illustrating how PaO2 changes with increasing MAC for each anesthetic agent.*
FDA Label Image

Figure 2. Desflurane Washin (Image 03)

Figure 2. Desflurane Washin (Image 03)
A line graph depicting the mean end-tidal to inspired anesthetic concentration ratio (FA/FI) over time in minutes for four anesthetic agents: Nitrous Oxide, Desflurane, Isoflurane, and Halothane, based on data from eight normal male volunteers. The graph compares the uptake rates of these agents during the first 30 minutes of administration.*
FDA Label Image

Figure 3. Desflurane Washout (Image 04)

Figure 3. Desflurane Washout (Image 04)
A line graph depicting the end-tidal anesthetic concentration (FA/FA0) over time in minutes for three anesthetics: Halothane, Isoflurane, and Desflurane. The graph includes mean ± SD values for 8 normal male volunteers, showing how the concentration decreases over approximately 150 minutes, with Desflurane decreasing faster than the others.*
FDA Label Image

Suprane Amerinet Choice Representative Container Label Ndc 10019-646-24 (Image 05)

Suprane Amerinet Choice Representative Container Label Ndc 10019-646-24 (Image 05)
Suprare (desflurane, USP) liquid for inhalation, 240 mL, prescription only. The label shows NDC 10019-646-24 and identifies it as a respiratory anesthetic. Manufactured for Baxter Healthcare Corporation and Amerinet Choice. Storage instructions and safety information are included.*
FDA Label Image

Suprane Amerinet Choice Representative Carton Label Ndc 10019-646-34 (Image 06)

Suprane Amerinet Choice Representative Carton Label Ndc 10019-646-34 (Image 06)
Label for SUPRANE (desflurane, USP) liquid inhalation anesthetic. The label indicates an NDC of 10019-646-34 and packaging of 6 bottles, each 240 mL. Storage instructions specify room temperature between 15° and 30°C (59°-86°F). The product is manufactured for Baxter Healthcare Corporation, Deerfield, IL, and Amerinet Choice, St. Louis, MO.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.